W. Robert Bishop - Concepedia

Author

W. Robert Bishop

Also Known As

W R Bishop, W Robert Bishop, W. R. BISHOP, W. R. Bishop, W. ROBERT BISHOP, W. Robert Bishop, W.R. Bishop, W.Robert Bishop, Walter Robert Bishop

126

Publications

8.8K

Citations

H-Index

Concepts

All Affiliations

AGCO (United Kingdom)AIL Research (United States)Bloomfield College Duke Medical Center Duke University Hospital

About

W. Robert Bishop is an author at AGCO (United Kingdom) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	44	4K
2	Biochemistry	22	29	1.6K
3	Natural Sciences	19	27	1.5K
4	Health Sciences	3	3	808
5	Engineering	2	2	94

W. Robert Bishop

Publications

Citations

H-Index

Page 1

	Year	Citations
Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. J Preiss, Carson R. Loomis, W. Robert Bishop, Journal of Biological Chemistry	1986	987
K- and N-Ras Are Geranylgeranylated in Cells Treated with Farnesyl Protein Transferase Inhibitors David B. Whyte, Paul T. Kirschmeier, Tish Hockenberry, Journal of Biological Chemistry	1997	872
Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors Erick J. Morris, Sharda Jha, Clifford R. Restaino, Cancer Discovery PharmacotherapyTumor BiologyDrug ResistanceMek InhibitorsReceptor Tyrosine Kinase	2013	673
Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway Asra Mirza, Marnie McGuirk, Tish Hockenberry, Oncogene Tumor BiologyWild-type P53P53-dependent Apoptotic PathwayPathologyTumor Suppressor	2002	534
Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson–Gilford progeria syndrome Leslie B. Gordon, Monica E. Kleinman, David T. Miller, Proceedings of the National Academy of Sciences	2012	365
Farnesyl Transferase Inhibitors Block the Farnesylation of CENP-E and CENP-F and Alter the Association of CENP-E with the Microtubules Hena R. Ashar, Linda James, Kimberly Gray, Journal of Biological Chemistry	2000	320
Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice. Ming Liu, Matthew Bryant, Jianping Chen, PubMed Sch 66336Chemoprevention StrategyFarnesyl Protein TransferaseOncogenic AgentMedicine	1998	309
A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity. Alex A. Adjei, Charles Erlichman, J. Nathan Davis, PubMed Chemoprevention StrategyPathologyPharmacotherapyTumor BiologyTranslational Pharmacology	2000	243
Characterization of Ha-Ras, N-Ras, Ki-Ras4A, and Ki-Ras4B as in Vitro Substrates for Farnesyl Protein Transferase and Geranylgeranyl Protein Transferase Type I Fang L. Zhang, Paul T. Kirschmeier, Donna Carr, Journal of Biological Chemistry	1997	202
Identification and Characterization of Zinc Binding Sites in Protein Kinase C Stevan R. Hubbard, W. Robert Bishop, Paul T. Kirschmeier, Science Zinc Binding SitesRat Pkc BetaMolecular BiologyReceptor Tyrosine KinaseProteomics	1991	196

Page 1